Patent details

EP3572417 Title: 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

Basic Information

Publication number:
EP3572417
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP191692839
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
French Title of Invention:
COMPOSÉS DE 19-NOR PRÉGNANE DISUBSTITUÉS 3,3, COMPOSITIONS ET LEURS UTILISATIONS
German Title of Invention:
3,3-DISUBSTITUIERTE 19-NOR-PREGNAN VERBINDUNGEN, ZUSAMMENSETZUNGEN DAMIT UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
12/10/2012
Grant date:
17/12/2025
EP Publication Date:
27/11/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/12/2025
EP B1 Publication Date:
17/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/10/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/12/2025
 
 

Name:
Sage Therapeutics, LLC
Address:
9715 Key West Avenue, Rockville, MD 20850, United States (US)

Inventor

1

Name:
SALITURO, Francesco, G.
Address:
United States (US)

2

Name:
UPASANI, Ravindra, B.
Address:
United States (US)

3

Name:
ASKEW, Benny, C.
Address:
United States (US)

4

Name:
HARRISON, Boyd, L.
Address:
United States (US)

5

Name:
ROBICHAUD, Albert, J.
Address:
United States (US)

Priority

1

Priority Number:
201161547291 P
Priority Date:
14/10/2011
Priority Country:
United States (US)

2

Priority Number:
201261698204 P
Priority Date:
07/09/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07J 5/00; C07J 7/00; C07J 31/00; C07J 43/00; A61K 31/57; A61K 31/573; A61K 31/58; A61P 25/00;

Publication

European Patent Bulletin

1

Issue number:
202551
Publication date:
17/12/2025
Description:
Grant (B1)

2

Issue number:
202603
Publication date:
14/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages